Bank Of Montreal Biomarin Pharmaceutical Inc Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bank Of Montreal holds 82,671 shares of BMRN stock, worth $5.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,671

Previous 250,925 67.05%

Holding current value

$5.48 Million

Previous $20.7 Million 71.88%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $11.6 Million - $15.8 Million	-168,254 Reduced 67.05%	82,671 $5.81 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $13.5 Million - $16.8 Million	181,935 Added 263.71%	250,925 $20.7 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $46,849 - $55,341	559 Added 0.82%	68,990 $6.03 Million
Q4 2023 Feb 08, 2024	SELL	$76.22 - $98.51 $17.1 Million - $22.1 Million	-224,356 Reduced 76.63%	68,431 $6.6 Million
Q3 2023 Nov 01, 2023	BUY	$85.07 - $94.48 $18.8 Million - $20.8 Million	220,464 Added 304.83%	292,787 $25.9 Million
Q2 2023 Aug 02, 2023	SELL	$86.68 - $100.3 $3.72 Million - $4.31 Million	-42,951 Reduced 37.26%	72,323 $6.27 Million
Q1 2023 Jun 13, 2024	BUY	$87.74 - $117.27 $4.11 Million - $5.49 Million	46,840 Added 67.89%	115,830 $11.3 Million
Q4 2022 Feb 01, 2023	BUY	$80.93 - $108.63 $3.12 Million - $4.19 Million	38,582 Added 50.31%	115,274 $11.9 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $14.9 Million - $17.6 Million	-181,686 Reduced 70.32%	76,692 $6.6 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $1.96 Million - $2.38 Million	27,454 Added 11.89%	258,378 $22.1 Million
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $5.59 Million - $6.98 Million	75,322 Added 48.41%	230,924 $18.3 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $843,068 - $1.08 Million	11,755 Added 8.17%	155,602 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $720,184 - $823,247	9,632 Added 7.18%	143,847 $11.1 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $10.1 Million - $11.4 Million	134,215 New	134,215 $11.2 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account